St. Jude Medical (STJ) Reports In-Line Q4 EPS; Issues Light Q1 EPS Outlook
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Price: $80.82 --0%
Financial Fact:
Cash dividends declared per share:: 0.31
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Financial Fact:
Cash dividends declared per share:: 0.31
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Join SI Premium – FREE
St. Jude Medical (NYSE: STJ) reported Q4 EPS of $1.03, in-line with the analyst estimate of $1.03. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.44 billion.
St. Jude Medical sees Q1 2015 EPS of $0.90-$0.92, versus the consensus of $0.97.
For earnings history and earnings-related data on St. Jude Medical (STJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
- Bunge Limited (BG) Tops Q1 EPS by 50c, misses on revenue and guidance
- Biogen (BIIB) Tops Q1 EPS by 24c; reaffirms guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
